New roles for p21 and p27 cell-cycle inhibitors: A function for each cell compartment?

Trends in Cell Biology

Volumn 13, Issue 2, 2003, Pages 65-70

  Coqueret, Olivier ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; PROTEIN P21; PROTEIN P27;

APOPTOSIS; CATALYSIS; CELL COMPARTMENTALIZATION; CELL CYCLE; CELL DIVISION; DNA DAMAGE; ENZYME ACTIVITY; MITOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; TRANSCRIPTION INITIATION;

EID: 0037304898     PISSN: 09628924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8924(02)00043-0     Document Type: Article

References (40)

1. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1999;1501-1512.
2. Russo A.A., et al. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex. Nature. 382:1996;325-331.
3. Olashaw N., Pledger W.J. Paradigms of growth control: relation to Cdk activation. Sci. STKE. 2002;RE7.
4. Bouchard C., et al. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 18:1999;5321-5333.
5. Cheng M., et al. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1999;1571-1583.
6. Muller D., et al. Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60. EMBO J. 19:2000;2168-2180.
7. Alt J.R., et al. p21(Cip1) Promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J. Biol. Chem. 277:2002;8517-8523.
8. Bunz F., et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science. 282:1998;1497-1501.
9. Gorospe M., et al. Protective role of p21(Waf1/Cip1) against prostaglandin A2-mediated apoptosis of human colorectal carcinoma cells. Mol. Cell. Biol. 16:1996;6654-6660.
10. Gorospe M., et al. p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells. Oncogene. 14:1997;929-935.
11. Seoane J., et al. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature. 419:2002;729-734.
12. Chang B.D., et al. Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases. Proc. Natl. Acad. Sci. U. S. A. 97:2000;4291-4296.
13. Asada M., et al. Apoptosis inhibitory activity of cytoplasmic p21(Cip1/WAF1) in monocytic differentiation. EMBO J. 18:1999;1223-1234.
14. Tanaka H., et al. Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity. J. Cell Biol. 158:2002;321-329.
15. Shim J., et al. A non-enzymatic p21 protein inhibitor of stress-activated protein kinases. Nature. 381:1996;804-806.
16. Suzuki A., et al. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene. 17:1998;931-939.
17. Suzuki A., et al. Mitochondrial regulation of cell death: mitochondria are essential for procaspase 3-p21 complex formation to resist Fas-mediated cell death. Mol. Cell. Biol. 19:1999;3842-3847.
18. Levkau B., et al. Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol. Cell. 1:1998;553-563.
19. Philipp-Staheli J., et al. p27(Kip1): regulation and function of a haploinsufficient tumor suppressor and its misregulation in cancer. Exp. Cell Res. 264:2001;148-168.
20. Eymin B., et al. p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells. Oncogene. 18:1999;1411-1418.
21. Woltman A.M., et al. Rapamycin specifically interferes with GM-CSF signaling in human dendritic cells leading to apoptosis via increased p27KIP1 expression. Blood. 2002;26. in press.
22. Fero M.L., et al. The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature. 396:1998;177-180.
23. Slingerland J., Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J. Cell. Physiol. 183:2000;10-17.
24. Viglietto G., et al. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat. Med. 8:2002;1136-1144.
25. Boehm M., et al. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J. 21:2002;3390-3401.
26. Eymin B., et al. Caspase-induced proteolysis of the cyclin-dependent kinase inhibitor p27Kip1 mediates its anti-apoptotic activity. Oncogene. 18:1999;4839-4847.
27. Westbrook T.F., et al. E7 Abolishes Raf-Induced Arrest via Mislocalization of p21(Cip1). Mol. Cell. Biol. 22:2002;7041-7052.
28. Zhou B.P., et al. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat. Cell Biol. 3:2001;245-252.
29. Rossig L., et al. Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol. Cell. Biol. 21:2001;5644-5657.
30. Gulli M.P., Peter M. Temporal and spatial regulation of Rho-type guanine-nucleotide exchange factors: the yeast perspective. Genes Dev. 15:2001;365-379.
31. Fahraeus R., Lane D.P. The p16(INK4a) tumour suppressor protein inhibits alphavbeta3 integrin- mediated cell spreading on vitronectin by blocking PKC-dependent localization of alphavbeta3 to focal contacts. EMBO J. 18:1999;2106-2118.
32. Bao W., et al. Cell attachment to the extracellular matrix induces proteasomal degradation of p21(CIP1) via Cdc42/Rac1 signaling. Mol. Cell. Biol. 22:2002;4587-4597.
33. Reed S.I. Cell cycling? Check your brakes. Nat. Cell Biol. 4:2002;E199-E201.
34. Boehm M., Nabel E.G. Cell cycle and cell migration: new pieces to the puzzle. Circulation. 103:2001;2879-2881.
35. Kitaura H., et al. Reciprocal regulation via protein-protein interaction between c-Myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J. Biol. Chem. 275:2000;10477-10483.
36. Coqueret O., Gascan H. Functional interaction of STAT3 transcription factor with the cell cycle inhibitor p21WAF1/CIP1/SDI1. J. Biol. Chem. 275:2000;18794-18800.
37. Harris T.E., et al. CCAAT/enhancer-binding protein-alpha cooperates with p21 to inhibit cyclin-dependent kinase-2 activity and induces growth arrest independent of DNA binding. J. Biol. Chem. 276:2001;29200-29209.
38. Snowden A.W., et al. A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation. Mol. Cell. Biol. 20:2000;2676-2686.
39. Delavaine L., La Thangue N.B. Control of E2F activity by p21Waf1/Cip1. Oncogene. 18:1999;5381-5392.
40. Chamovitz D.A., Segal D. JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Rep. 2:2001;96-101.